| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |